Next generation genome sequencer. (360G-Wellcome-088000_Z_08_Z)
The sequencing of large numbers of genomes has opened up numerous new exciting possibilities for novel avenues of research on a scale that was previously impossible to contemplate. More recent technological advances such as next generation sequencers have further accelerated our ability to ask questions about how the genome behaves and is modified. There are three major applications of this technology; genome resequencing (eg for mutation detection), RNA-Seq (for analysing global gene expressi on patterns) and ChIP-Seq (eg for identifying transcription factor binding sites). All these approaches map onto projects that are currently being pursued by researchers at the University of Manchester but which cannot currently be executed to their full potential due to the lack of this technology in house. In particular, several projects will be facilitated by ChIP-Seq and are centred on understanding how the genome is regulated by transcription factors and chromatin modifications in a dynamic manner. Genome sequencing will be used to help find the molecular causes underlying human disease and provide an evolutionary insight into the construction of gene regulatory modules. Moreover there is also a growing realisation that RNA-Seq is an essential discovery tool for interrogating gene expression changes in the cell.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 399076 |
Applicant Surname | Sharrocks |
Approval Committee | Molecules, Genes and Cells Funding Committee |
Award Date | 2009-04-28T00:00:00+00:00 |
Financial Year | 2008/09 |
Grant Programme: Title | Equipment & Resources: Inactive Scheme |
Internal ID | 088000/Z/08/Z |
Lead Applicant | Prof Andrew Sharrocks |
Other Applicant(s) | Dr Casey Bergman, Dr Catherine Millar, Prof Graeme Black, Prof Michael Dixon |
Partnership Value | 399076 |
Planned Dates: End Date | 2012-11-30T00:00:00+00:00 |
Planned Dates: Start Date | 2009-10-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | North West |